Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Beneficial effects of TDN-345 in animal models of cerebrovascular disease

Sep. 5, 1997

Generic methylphenidate approved in U.S.

Sep. 5, 1997

NeuroSearch compound enters phase I for treatment of dementia

Sep. 4, 1997

Neurobiological Technologies files IND for antiedema agent

Sep. 4, 1997

Subtype-selective NMDA receptor ligands reported

Sep. 4, 1997

First approval for Zeneca's Seroquel

Sep. 3, 1997

Tasmar launched in U.K., Germany

Sep. 3, 1997

Neuroprotection with new lipid peroxidation inhibitor from Lilly

Sep. 2, 1997

Migraine prophylaxis with bisoprolol

Sep. 1, 1997

Famotidine for schizophrenia

Sep. 1, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Science
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Asia
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...